Updated Jul 16, 2026
MPM BIOVENTURES 2018, L.P. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $20.03M. Lifetime open-market sales: $917K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-14 | AKTS | Aktis Oncology, Inc. | P — Open-market purchase | 1.11M | $18.00 | $20.03M |
| 2026-01-14 | AKTS | Aktis Oncology, Inc. | J — Other acquisition / disposition | 1.58M | — | |
| 2026-01-14 | AKTS | Aktis Oncology, Inc. | J — Other acquisition / disposition | 5.91M | — | |
| 2026-01-14 | AKTS | Aktis Oncology, Inc. | J — Other acquisition / disposition | 1.31M | — | |
| 2024-12-12 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 21.8K | $20.23 | $441K |
| 2024-12-12 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 22.9K | $20.77 | $476K |
MPM BIOVENTURES 2018, L.P. is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 1 open-market purchases ($20.03M) and 2 open-market sales ($917K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MPM BIOVENTURES 2018, L.P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.